Apricus Biosciences Announces National Phase Approval for Vitaros in Spain By: Benzinga via Benzinga April 24, 2014 at 08:08 AM EDT Apricus Biosciences, Inc. (Nasdaq: APRI), a pharmaceutical company focusing on the development and commercialization of novel ... Read More >>